Page 1 of Clinical Trials for Amsterdam Molecular Therapeutics [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Suspended
Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Last Updated: March 14, 2012
Condition(s): Hyperlipoproteinemia Type I
2
Completed
Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Last Updated: September 28, 2011
Condition(s): Familial Lipoprotein Lipase Deficiency
3
Enrolling by invitation
Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies
Last Updated: October 6, 2011
Condition(s): Lipoprotein Lipase Deficiency
4
Active, not recruiting
Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Last Updated: September 29, 2011
Condition(s): Familial Lipoprotein Lipase Deficiency

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Amsterdam+Molecular+Therapeutics

Page 1 of Clinical Trials for Amsterdam Molecular Therapeutics [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About